GPCR (Structure Therapeutics Inc) Earnings per share for the last four quarters
Structure Therapeutics utilizes algorithms to develop diabetes treatments by delegating synthesis to robots. This chart of net income per share YoY ttm illustrates profitability trends, where -8.20 represents the current level of the metric. While AI platforms here automate small molecule design, the clinical testing stage for oral obesity drugs requires significant R&D capital expenditures.
%20%5Blogo%5D%20GPCR&width=1200&height=400&colorIndex=0&v=mwczyyub.rjb-7czcsu8&start=20220704&end=20261112&filename=GURU_Markets_-_GPCR_-_Structure-Therapeutics_-_Net-earnings-per-share-EPS-TTM "GPCR (Structure Corp) Net earnings per share (EPS TTM) history from 02/11/2024 to 11/12/2026 | 👁️GURU.Markets👁️")
GPCR (Structure Pharma): analytical breakdowns and indicator data
- price and consensus price forecast:
- business market valuation indicators:
- business book valuation details:
- company total debt and liquidity indicators:
Debt to Capital Structure Therapeutics|GPCR - Long-Term Debt to Equity|Short-Term Debt to Equity Structure Corp|GPCR - Company Aggregate Debts|Debts to Net Assets Structure Therapeutics Inc|GPCR - Company Long-Term Debt|Short-Term Debt Volume Structure Therapeutics|Quick Liquidity Indicator structuretx.com
- earnings and multiples data:
GPCR - Company Net Income|Company Profit Forecast Structure Therapeutics|GPCR - Price to Earnings Ratio|Market Cap to Future Earnings Ratio Structure Therapeutics Inc|GPCR - Price/Earnings to Growth Ratio|Business Value to Operating Income Before Depreciation Structure Therapeutics Inc|GPCR - Operating profit before deduction of amortization|Net earnings per share (EPS TTM) Structure Therapeutics|GPCR - Net earnings per share (EPS TTM)|Year-over-year net earnings per share growth for the last 12 months structuretx.com|GPCR - Net earnings per share growth this year|Projected earnings per share increase next year Structure Therapeutics
Fundamental company valuation:GPCR (structuretx.com)
Structure Therapeutics' bet on a narrow segment of anti-obesity drugs makes the company's operational success critically dependent on the outcome of clinical trials. By analyzing the trend of the EPS YoY TTM percentage change, an investor tracks the dynamics of net income per share over a rolling year, which allows for an assessment of the fundamental stability of the quotes through the prism of real earnings growth.
Competitor analysis
Net earnings per one share for the last twelve months ascendispharma.com|MDGL (Madrigal Pharmaceuticals, Inc.) - Net earnings per share for the last 12 months|CORT: Earnings per share for the last four quarters|RYTM (Rhythm Pharmaceuticals Inc) - Net earnings per share (EPS TTM)|Net earnings per share (EPS TTM) Akero Corp|Net earnings per share (EPS TTM) MTSR|Earnings per share for the last twelve months MLTX (moonlaketx.com)|Earnings per share for the last twelve months Crinetics CRNX|NewAmsterdam Pharma Company (NAMS) - Net earnings per one share for the last twelve months|SLNO - Earnings per share for the last twelve months|FOLD: Earnings per share for the last twelve months|ETNB: Net earnings per share (EPS TTM)|AGIO - Net earnings per share for the last four quarters|Earnings per share for the last twelve months MiMedx|Rezolute Inc (RZLT) - Net earnings per share for the last four quarters|Earnings per share for the last twelve months Lexicon Pharma (LXRX)|Net earnings per share for the last 12 months MBX Corp MBX|Earnings per share for the last twelve months Altimmune, Inc. ALT|Net earnings per share for the last four quarters aardvarktherapeutics.com (AARD)|SGMT: Net earnings per share for the last 12 months|BioAge Labs - Earnings per share for the last four quarters|Biomea (BMEA) - Earnings per share for the last twelve months|Quince Therapeutics, Inc. - Earnings per share for the trailing year|Net earnings per share for the last 12 months GUTS|Net earnings per share (EPS TTM) vTv Therapeutics Inc|Net earnings per share (EPS TTM) ATPC|Net earnings per share for the last 12 months pluri-biotech.com PLUR|Synlogic - Net earnings per share for the last 12 months|Earnings per share for the last four quarters LPCN (Lipocine Corporation)|MTNB: Net earnings per share for the last 12 months|SPRB - Net earnings per share (EPS TTM)|Galecto (GLTO) - Earnings per share for the last twelve months|Carmell Corp. - Earnings per share for the trailing year|LUMO (Lumos Pharma Corp) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Organovo Corp ONVO|Net earnings per share for the last 12 months RDUS (Radius Recycling, Inc.)
